![]() |
市场调查报告书
商品编码
1843564
2025年全球医疗设备人工智慧市场报告AI In Medical Devices Global Market Report 2025 |
||||||
近年来,人工智慧在医疗设备领域的市场规模迅速扩张,从2024年的100.8亿美元成长到2025年的123.8亿美元,复合年增长率达22.8%。这一增长主要归功于早期机器学习演算法的出现、巨量资料分析的兴起、精准医疗需求的不断增长、监管部门的支持和核准,以及放射学领域的早期应用。
预计未来几年,人工智慧在医疗设备领域的市场规模将呈指数级增长,到2029年将达到342亿美元,复合年增长率(CAGR)为28.9%。预测期内的成长可归因于以患者为中心的医疗模式、医疗保健支出的增加、监管支援和标准的提升、临床决策支援的增强以及人工智慧在疾病预测和预防方面的应用。预测期内的关键趋势包括增强放射学和影像学、人工智慧赋能的病理诊断、基因组学与人工智慧的融合、医疗保健领域的预测分析以及自然语言处理(NLP)。
其目标是透过整合先进的演算法、机器学习技术和其他人工智慧(AI)技术,提升医疗设备的效能和功能。将人工智慧应用于医疗设备将有助于提高诊断准确性、辅助外科手术、预测患者预后以及製定个人化治疗方案。
人工智慧在医疗设备中的部署方式主要有两种:云端部署和本地部署。云端部署利用互联网上的远端伺服器网路来储存、处理和管理数据,而不是依赖本机伺服器或个人电脑。这种方法涵盖多种技术,包括情境感知、深度学习、机器学习、自然语言处理和预测分析。这些技术应用于许多领域,包括患者治疗、诊断和监测。人工智慧在医疗设备中的主要最终用户包括医院和医疗服务提供者、患者、製药和生物技术公司以及医疗保险机构。
美国在2025年春季突然提高关税及其引发的贸易摩擦,对资讯科技产业,特别是硬体製造、资料基础设施和软体部署领域,产生了重大影响。进口半导体、电路基板和网路设备的关税上涨,推高了高科技公司、云端服务供应商和资料中心的生产和营运成本。在全球范围内采购笔记型电脑、伺服器和消费电子产品零件的公司,面临更长的前置作业时间和价格压力。同时,对专用软体征收的关税以及主要国际市场的报復性措施,扰乱了全球IT供应链,并降低了海外对美国製造技术的需求。为了应对这些挑战,该产业正在加大对国内晶片生产的投资,扩大供应商网络,并利用人工智慧驱动的自动化技术来增强韧性,更有效地控製成本。
本研究报告是商业研究公司(The Business Research Company)最新系列报告的一部分,该系列报告提供医疗设备人工智慧(AI)市场统计数据,包括全球市场规模、区域份额、医疗设备医疗设备医疗设备人工智慧市场细分、市场趋势和商业机会,为您提供在医疗设备人工智慧行业取得成功所需的数据。这份医疗设备人工智慧市场研究报告对该行业的现状和未来发展趋势进行了详细分析,为您提供所需的一切观点。
未来五年28.9%的预测成长率较我们先前对该市场的预测略微下降了0.6%。这一下降主要归因于美国与其他国家之间的关税影响。对美国,直接影响可能源自于对依赖瑞士和德国精密零件的人工智慧手术机器人征收的关税增加,这将减缓医疗保健领域的进步。此外,由于相互关税措施以及贸易紧张局势和限制措施升级对全球经济和贸易造成的负面影响,其影响范围也将更加广泛。
个人化医疗需求的不断增长预计将推动人工智慧在医疗设备市场的发展。个人化医疗是一种量身定制的医疗保健方法,它充分考虑患者的个别特征,例如遗传、环境和生活方式,以提高治疗效果和预后。基因组学的进步、病人自主权的增强以及治疗效果的改善等诸多因素共同促成了个人化医疗需求的成长。透过处理大量的患者数据,包括基因资讯、病历和生活习惯,人工智慧可以全面了解个体的特征,并帮助制定个人化的治疗方案。例如,总部位于美国的非营利组织「个人化医疗联盟」(Personalized Medicine Coalition)在2024年2月报告称,针对罕见疾病患者的新核准个人化治疗药物数量从2022年的6种增加到2023年的16种。因此,对个人化医疗日益增长的需求是推动人工智慧在医疗设备市场发展的重要动力。
预计未来几年,医疗保健支出的成长将推动人工智慧在医疗设备市场的发展。医疗保健支出涵盖所有用于提供医疗服务及相关活动的资源,包括资金和非资金。这部分支出对于人工智慧医疗设备的普及和应用至关重要,因为它使医疗服务提供者能够投资于先进技术,从而改善患者照护和治疗效果。例如,总部位于加拿大的非营利组织加拿大健康资讯研究所(Canadian Institute for Health Information)在2023年11月发布的报告显示,预计2023年医疗保健总支出将达到3,440亿美元,比前一年增长2.8%。因此,医疗保健支出的成长是推动人工智慧在医疗设备市场发展的关键因素。
医疗设备人工智慧市场正经历由技术进步驱动的重大趋势,领先企业积极采用新技术以维持其市场地位。 2022年3月,美国电脑硬体製造商英伟达公司发布了Clara Holoscan MGX平台,该平台专为医疗设备业设计,用于在边缘开发和部署即时人工智慧应用。这项创新平台有助于打造具备先进人工智慧功能的医疗设备,包括影像和讯号处理、自然语言处理和预测分析。此外,它还整合了先进的安全功能并符合医疗保健行业法规,以确保患者资料的安全性和隐私性,从而实现医疗资料的即时处理,并为临床决策提供有价值的资讯。
医疗设备人工智慧市场的主要企业正致力于建立策略联盟,以加速人工智慧在医疗保健系统中的发展并获得竞争优势。这些联盟旨在利用人工智慧增强药物发现、设计和开发,并利用机器学习提高医疗设备製造效率并降低风险。 2023年3月,总部位于爱尔兰的医疗设备公司Medtronic)与总部位于美国的软体公司英伟达(NVIDIA)合作,共同建构一个用于医疗设备的人工智慧平台。此次合作将把英伟达的医疗保健和边缘人工智慧技术整合到MedtronicGI Genius智慧内视镜模组中,这是首个获得FDA核准的人工智慧辅助大肠镜检查工具。这项策略伙伴关係旨在加速人工智慧在医疗保健系统中的应用,并为患者照护引入新的人工智慧解决方案。
2023年2月,总部位于美国的医疗技术和诊断公司GE医疗科技以30亿美元完成了对Caption Health Inc.的收购。此次收购旨在扩大Caption Health Inc.开发的Caption AI的应用范围,使其从循环系统领域扩展到包括初级保健、急诊医学和妇产科在内的多个医疗专科。 Caption Health以其在人工智慧医疗产品製造方面的专业技术而闻名,此次收购将使GE医疗科技能够将人工智慧创新带给更广泛的临床医生和医疗专科。
医疗设备设备市场的主要参与者包括:通用电气公司、美敦力公司、西门子医疗公司、美光科技公司、英伟达公司、英特尔公司、国际商业机器公司、亚马逊网路服务公司、皇家飞利浦公司、Enlitic公司、Cloudmedx公司、Oncora Medical、微软公司、Path AI公司、Aidoc Medicalics、Afunc一天运动公司、AliveAliveAliveTery、Afociiing. AI公司、Babylon Health有限公司、Brainomix有限公司、Butterfly Network公司、佳能医疗系统公司、Cerner公司、Clarapass公司、Comarch SA公司、CureMetrix公司、DeepMind Health公司、Diabetic Retinopathy Detection有限公司、Diacron集团、Diagnostic Robotics公司和EchoPixel公司。
2024年,北美是人工智慧在医疗设备市场中最大的地区。人工智慧在医疗设备市场报告涵盖以下地区:亚太地区、西欧、东欧、北美、南美、中东和非洲。
这份《人工智慧在医疗设备中的应用市场报告》涵盖以下国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙。
医疗设备人工智慧市场由提供医疗设备人工智慧服务的营业单位所获得的收入构成,例如诊断和治疗计划、远端监控和机器人手术。市场价值包括服务供应商销售的相关产品或包含在其服务产品中的相关产品的价值。医疗设备人工智慧市场还包括用于提供医疗设备服务的诊断影像系统、穿戴式装置、电子健康记录(EHR)、机器人手术系统和人工智慧监控设备的销售额。该市场的价值为“出厂价”,即製造商或产品创造者销售的商品价值,无论销售对像是其他营业单位(包括下游製造商、批发商、经销商和零售商)还是直接销售给最终客户。该市场中的商品价值还包括产品创造者销售的任何相关服务。
The utilization of advanced algorithms, machine learning techniques, and other artificial intelligence (AI) technologies in medical devices aims to enhance their performance and capabilities. This integration of AI in medical devices contributes to improved diagnostic accuracy, assistance in surgical procedures, prediction of patient outcomes, and the personalization of treatment plans.
AI in medical devices can be deployed through two main methods, cloud and on-premise. Cloud deployment involves utilizing a remote server network for data storage, processing, and management over the Internet, as opposed to relying on a local server or personal computer. This approach encompasses various technologies such as context awareness, deep learning, machine learning, natural language processing, predictive analytics, among others. These technologies find applications in diverse areas such as patient care, treatment, diagnosis, monitoring, and more. The primary end-users of AI in medical devices include hospitals and healthcare providers, patients, pharmaceutical and biotechnology companies, as well as healthcare payers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.
The AI in medical devices market research report is one of a series of new reports from The Business Research Company that provides AI in medical devices market statistics, including AI in medical devices industry global market size, regional shares, competitors with AI in medical devices market share, detailed AI in medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the AI in medical devices industry. This AI in medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ai in medical devices market size has grown exponentially in recent years. It will grow from $10.08 billion in 2024 to $12.38 billion in 2025 at a compound annual growth rate (CAGR) of 22.8%. The growth in the historic period can be attributed to early machine learning algorithms, a rise in big data analytics, increased demand for precision medicine, regulatory support and approvals, and early adoption in radiology.
The ai in medical devices market size is expected to see exponential growth in the next few years. It will grow to $34.2 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%. The growth in the forecast period can be attributed to a patient-centric approach, increasing healthcare expenditure, regulatory support and standards, enhanced clinical decision support, and AI in disease prediction and prevention. Major trends in the forecast period include augmented radiology and imaging, AI-powered pathology, genomics and AI integration, predictive analytics in healthcare, and natural language processing (NLP).
The forecast of 28.9% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by raising tariffs on AI-enhanced surgical robots, reliant on precision components from Switzerland and Germany, delaying healthcare advancements. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising demand for personalized medicine is anticipated to drive the growth of AI in the medical devices market in the future. Personalized medicine is a tailored healthcare approach that considers individual patient characteristics, such as genetics, environment, and lifestyle, to improve treatment effectiveness and outcomes. Several factors contribute to the increasing demand for personalized medicine, including advancements in genomics, greater patient empowerment, and enhanced treatment efficacy. AI processes vast amounts of patient data, encompassing genetic information, medical histories, and lifestyle factors, to develop a comprehensive understanding of individual profiles, which in turn supports the creation of customized treatment plans. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported in February 2024 that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the growing demand for personalized medicine is a key driver of growth for AI in the medical devices market.
The rise in healthcare expenditure is expected to boost the growth of AI in the medical device market in the coming years. Healthcare expenditure encompasses all resources, both financial and non-financial, allocated to the delivery of health services and related activities. This spending is crucial for the adoption and utilization of AI medical devices, as it allows healthcare providers to invest in advanced technologies that enhance patient care and outcomes. For instance, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in November 2023 that total health expenditure is anticipated to reach $344 billion in 2023, representing a modest increase of 2.8% from the previous year. Consequently, the rise in healthcare expenditure is a significant factor driving the growth of AI in the medical device market.
The AI in medical devices market is experiencing a significant trend driven by technological advancements, with major companies actively adopting new technologies to maintain their market positions. In March 2022, Nvidia Corporation, a US-based computer hardware manufacturing company, introduced the Clara Holoscan MGX, a platform specifically designed for the medical device industry to develop and deploy real-time AI applications at the edge. This innovative platform facilitates the creation of medical devices with advanced AI capabilities, including image and signal processing, natural language processing, and predictive analytics. Furthermore, it incorporates advanced security features and compliance with healthcare industry regulations to ensure the safety and privacy of patient data, allowing real-time processing of medical data and providing valuable insights for clinical decision-making.
Strategic collaborations are a key focus for major companies in the AI in medical devices market, aiming to accelerate the development of AI in the healthcare system and gain a competitive advantage. These collaborations are geared towards leveraging AI to enhance drug discovery, design, and development, as well as improving medical device manufacturing efficiency and risk reduction through machine learning. In March 2023, Medtronic, an Ireland-based medical device company, partnered with NVIDIA Corporation, a US-based software company, to build an AI platform for medical devices. This collaboration involves integrating NVIDIA healthcare and edge AI technology into the Medtronic GI Genius intelligent endoscopy module, the first FDA-approved AI-assisted colonoscopy tool. The strategic partnership aims to expedite the incorporation of AI into the healthcare system and introduce new AI-based solutions for patient care.
In February 2023, GE HealthCare Technologies Inc., a US-based healthcare technology and diagnostics company, completed the acquisition of Caption Health Inc. for $3 billion. This acquisition was driven by the goal of expanding the use cases of Caption AI, developed by Caption Health Inc., beyond cardiology to various medical specialties such as primary care, emergency medicine, and obstetrics. Caption Health Inc. is recognized for its expertise in producing AI medical products, and this acquisition positions GE HealthCare Technologies Inc. to bring AI innovations to a broader range of clinicians and medical specialties.
Major companies operating in the AI in medical devices market include General Electric Company, Medtronic plc., Siemens Healthineers AG, Micron Technology Inc., Nvidia Corporation, Intel Corporation, International Business Machines Corporation, Amazon Web Services, Inc., Koninklijke Philips N.V., Enlitic Inc., Cloudmedx Inc., Oncora Medical Inc., Microsoft Corporation, Path AI Inc., Aidoc Medical Ltd., Accuray Incorporated, AliveCor, Alphabet Inc., Apple Inc., Arterys Inc., Augmedics Inc., Azra AI, Babylon Health Limited, Brainomix Ltd., Butterfly Network Inc., Canon Medical Systems Corporation, Cerner Corporation, Clarapass Inc., Comarch SA, CureMetrix Inc., DeepMind Health, Diabetic Retinopathy Detection Ltd., Diacron Group, Diagnostic Robotics, EchoPixel Inc.
North America was the largest region in the AI in medical devices market in 2024. The regions covered in the ai in medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the ai in medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The AI in medical devices market consists of revenues earned by entities by providing AI in medical devices such as diagnosis and treatment planning, remote monitoring, and robotic surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in medical devices market also includes sales of diagnostic imaging systems, wearable devices, electronic health records (EHRs), robotic surgical systems, and AI monitoring devices, which are used in providing AI in medical devices services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI In Medical Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ai in medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ai in medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in medical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.